聚乙二醇衍生物及其蛋白药物修饰研究进展
投稿时间:2017-11-23  修订日期:2018-03-30  点此下载全文
引用本文:张羽,连治国,徐明波,冯芳.聚乙二醇衍生物及其蛋白药物修饰研究进展[J].药学实践杂志,2018,36(4):301~306,328
摘要点击次数: 1782
全文下载次数: 1991
作者单位E-mail
张羽 中国药科大学, 江苏 南京 210009
北京双鹭药业股份有限公司, 北京 100041 
 
连治国 北京双鹭药业股份有限公司, 北京 100041  
徐明波 北京双鹭药业股份有限公司, 北京 100041  
冯芳 中国药科大学, 江苏 南京 210009 yaoxuefengfang@163.com 
中文摘要:聚乙二醇及其衍生物因其出色的亲水性、生物相容性、生物学惰性等特性而被广泛应用于蛋白药物修饰,其修饰可有效降低蛋白药物的免疫原性并延长体内半衰期。聚乙二醇衍生物的发展经历了第一代随机修饰,第二代特异性和功能性修饰,以及第三代分支型结构的应用。其应用也从简单的药物修饰扩展到生物传感、药物传输等方面。
中文关键词:聚乙二醇衍生物  聚乙二醇修饰  蛋白药物  长效
 
Advances in the development of PEG derivatives and pegylated protein drugs
Abstract:Polyethylene glycol and its derivatives are widely used in protein drug modification due to the excellent hydrophilicity, biocompatibility and bioinertia. The pegylation makes it possible that protein has lower immunogenicity and longer half-life. PEG derivatives had undergone three generations, from random modifications, to site-specific and functional modifications, and then branched structures. The application of PEG derivatives also extends to biosensing and drug delivery. Advances in the development of PEG derivatives and pegylated protein drugs were reviewed in this paper.
keywords:PEG derivatives  pegylation  protein drugs  long-acting
查看全文  查看/发表评论  下载PDF阅读器
关闭

分享按钮